{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-services-wales-regulations-2020/schedule-2/paragraph-28",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-services-wales-regulations-2020/schedule-2/paragraph-28.json",
  "legislation": "wsi/2020/1073",
  "legislation_title": "The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-services-wales-regulations-2020",
  "path": "schedule/2/paragraph/28",
  "kind": "paragraph",
  "number": "28",
  "heading": null,
  "text": "The applicant must supply the name of any Local Health Board (or equivalent body) in whose pharmaceutical list the applicant, and where the applicant is a body corporate, any director or superintendent of the applicant, is included, and particulars of any outstanding applications (including deferred applications) for inclusion in, or preliminary consent to be included in, any pharmaceutical list of a Local Health Board (or equivalent body) with the name of the Local Health Board (or body) in question.",
  "extent": "E+W",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. 2 para. 28 in force at 1.10.2020, see reg. 1(2)(b)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/wsi/2020/1073/schedule/2/paragraph/28",
    "retrieved_at": "2026-10-31T10:31:49.207634+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}